TY - JOUR
T1 - Smartphone-based physical activity telecoaching in chronic obstructive pulmonary disease
T2 - Mixed-methods study on patient experiences and lessons for implementation
AU - Loeckx, Matthias
AU - Rabinovich, Roberto A.
AU - Demeyer, Heleen
AU - Louvaris, Zafeiris
AU - Tanner, Rebecca
AU - Rubio, Noah
AU - Frei, Anja
AU - De Jong, Corina
AU - Gimeno-Santos, Elena
AU - Rodrigues, Fernanda M.
AU - Buttery, Sara C.
AU - Hopkinson, Nicholas S.
AU - Büsching, Gilbert
AU - Strassmann, Alexandra
AU - Serra, Ignasi
AU - Vogiatzis, Ioannis
AU - Garcia-Aymerich, Judith
AU - Polkey, Michael I.
AU - Troosters, Thierry
N1 - Funding Information:
The authors would like to acknowledge Claudia Perez for providing data from the Linkcare app, Maarten Spruit (MS) and Ane Arbillaga-Etxarri (AAE) for their contribution with the data collection. The PROactive project is funded by the Innovative Medicines Initiative Joint Undertaking (IMU JU) #115011. The Leuven study group was supported by the Flemish Research Foundation (grant # G.0871.13). HD was the recipient of a joint ERS/SEPAR Fellowship (LTRF 2015) and is a postdoctoral fellow of the FWO-Flanders. ZL was the recipient of a European Respiratory Society Fellowship, grant number LTRF 2016-6686 and is a postdoctoral fellow of the FWO-Flanders (Fellowship number 12U5618N). FMR is funded by The National Council for Scientific and Technological Development (CNPq), Brazil (249579/2013-8). The Zurich study group was supported by an additional grant of the Lung League Aargau (nonprofit organization) as well as by Swisscom AG who provided 30 sim cards and data usage of up to 1 GB per month. MIP’s contribution to this work was supported by the National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit at the Royal Brompton and Harefield National Health Services (NHS) Foundation Trust and Imperial College, London UK who part fund his salary. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The sponsors did not have any influence on the design, conduct, and analysis of the study. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.
Funding Information:
The authors would like to acknowledge Claudia Perez for providing data from the Linkcare app, Maarten Spruit (MS) and Ane Arbillaga-Etxarri (AAE) for their contribution with the data collection. The PROactive project is funded by the Innovative Medicines Initiative Joint Undertaking (IMU JU) #115011. The Leuven study group was supported by the Flemish Research Foundation (grant # G.0871.13). HD was the recipient of a joint ERS/SEPAR Fellowship (LTRF 2015) and is a postdoctoral fellow of the FWO-Flanders. ZL was the recipient of a European Respiratory Society Fellowship, grant number LTRF 2016-6686 and is a postdoctoral fellow of the FWO-Flanders (Fellowship number 12U5618N). FMR is funded by The National Council for Scientific and Technological Development (CNPq), Brazil (249579/2013-8). The Zurich study group was supported by an additional grant of the Lung League Aargau (nonprofit organization) as well as by Swisscom AG who provided 30 sim cards and data usage of up to 1 GB per month. MIP’s contribution to this work was supported by the National Institute for Health Research (NIHR) Respiratory Biomedical Research Unit at the Royal Brompton and Harefield National Health Services (NHS) Foundation Trust and Imperial College, London UK who part fund his salary. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The sponsors did not have any influence on the design, conduct, and analysis of the study. ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya.
Publisher Copyright:
© Matthias Loeckx, Roberto A Rabinovich, Heleen Demeyer, Zafeiris Louvaris, Rebecca Tanner, Noah Rubio, Anja Frei, Corina De Jong, Elena Gimeno-Santos, Fernanda M Rodrigues, Sara C Buttery, Nicholas S Hopkinson, Gilbert Büsching, Alexandra Strassmann, Ignasi Serra, Ioannis Vogiatzis, Judith Garcia-Aymerich, Michael I Polkey, Thierry Troosters.
PY - 2018/12
Y1 - 2018/12
N2 - Background: Telecoaching approaches can enhance physical activity (PA) in patients with chronic obstructive pulmonary disease (COPD). However, their effectiveness is likely to be influenced by intervention-specific characteristics. Objective: This study aimed to assess the acceptability, actual usage, and feasibility of a complex PA telecoaching intervention from both patient and coach perspectives and link these to the effectiveness of the intervention. Methods: We conducted a mixed-methods study based on the completers of the intervention group (N=159) included in an (effective) 12-week PA telecoaching intervention. This semiautomated telecoaching intervention consisted of a step counter and a smartphone app. Data from a project-tailored questionnaire (quantitative data) were combined with data from patient interviews and a coach focus group (qualitative data) to investigate patient and coach acceptability, actual usage, and feasibility of the intervention. The degree of actual usage of the smartphone and step counter was also derived from app data. Both actual usage and perception of feasibility were linked to objectively measured change in PA. Results: The intervention was well accepted and perceived as feasible by all coaches present in the focus group as well by patients, with 89.3% (142/159) of patients indicating that they enjoyed taking part. Only a minority of patients (8.2%; 13/159) reported that they found it difficult to use the smartphone. Actual usage of the step counter was excellent, with patients wearing it for a median (25th-75th percentiles) of 6.3 (5.8-6.8) days per week, which did not change over time (P=.98). The smartphone interface was used less frequently and actual usage of all daily tasks decreased significantly over time (P<.001). Patients needing more contact time had a smaller increase in PA, with mean (SD) of +193 (SD 2375) steps per day, +907 (SD 2306) steps per day, and +1489 (SD 2310) steps per day in high, medium, and low contact time groups, respectively; P for-trend=.01. The overall actual usage of the different components of the intervention was not associated with change in step count in the total group (P=.63). Conclusions: The 12-week semiautomated PA telecoaching intervention was well accepted and feasible for patients with COPD and their coaches. The actual usage of the step counter was excellent, whereas actual usage of the smartphone tasks was lower and decreased over time. Patients who required more contact experienced less PA benefits. Trial Registration: ClinicalTrials.gov NCT02158065; http://clinicaltrials.gov/ct2/show/NCT02158065 (Archived by WebCite at http://www.webcitation.org/73bsaudy9).
AB - Background: Telecoaching approaches can enhance physical activity (PA) in patients with chronic obstructive pulmonary disease (COPD). However, their effectiveness is likely to be influenced by intervention-specific characteristics. Objective: This study aimed to assess the acceptability, actual usage, and feasibility of a complex PA telecoaching intervention from both patient and coach perspectives and link these to the effectiveness of the intervention. Methods: We conducted a mixed-methods study based on the completers of the intervention group (N=159) included in an (effective) 12-week PA telecoaching intervention. This semiautomated telecoaching intervention consisted of a step counter and a smartphone app. Data from a project-tailored questionnaire (quantitative data) were combined with data from patient interviews and a coach focus group (qualitative data) to investigate patient and coach acceptability, actual usage, and feasibility of the intervention. The degree of actual usage of the smartphone and step counter was also derived from app data. Both actual usage and perception of feasibility were linked to objectively measured change in PA. Results: The intervention was well accepted and perceived as feasible by all coaches present in the focus group as well by patients, with 89.3% (142/159) of patients indicating that they enjoyed taking part. Only a minority of patients (8.2%; 13/159) reported that they found it difficult to use the smartphone. Actual usage of the step counter was excellent, with patients wearing it for a median (25th-75th percentiles) of 6.3 (5.8-6.8) days per week, which did not change over time (P=.98). The smartphone interface was used less frequently and actual usage of all daily tasks decreased significantly over time (P<.001). Patients needing more contact time had a smaller increase in PA, with mean (SD) of +193 (SD 2375) steps per day, +907 (SD 2306) steps per day, and +1489 (SD 2310) steps per day in high, medium, and low contact time groups, respectively; P for-trend=.01. The overall actual usage of the different components of the intervention was not associated with change in step count in the total group (P=.63). Conclusions: The 12-week semiautomated PA telecoaching intervention was well accepted and feasible for patients with COPD and their coaches. The actual usage of the step counter was excellent, whereas actual usage of the smartphone tasks was lower and decreased over time. Patients who required more contact experienced less PA benefits. Trial Registration: ClinicalTrials.gov NCT02158065; http://clinicaltrials.gov/ct2/show/NCT02158065 (Archived by WebCite at http://www.webcitation.org/73bsaudy9).
KW - COPD
KW - Outcome and process assessment (health care)
KW - Patient adherence
KW - Patient satisfaction
KW - Physical activity
KW - Smartphone
KW - Telemedicine
UR - http://www.scopus.com/inward/record.url?scp=85060340297&partnerID=8YFLogxK
U2 - 10.2196/mhealth.9774
DO - 10.2196/mhealth.9774
M3 - Article
AN - SCOPUS:85060340297
SN - 2291-5222
VL - 6
JO - JMIR mHealth and uHealth
JF - JMIR mHealth and uHealth
IS - 12
M1 - e200
ER -